Riksbank Lifts Policy Rate to 2.00% as Nomura Forecasts Higher Path
Nomura analysts project a higher policy path for the Riksbank following a rate hike to 2.00%, signaling a continued commitment to curbing…
Nomura analysts project a higher policy path for the Riksbank following a rate hike to 2.00%, signaling a continued commitment to curbing…
BrightBid Group has reached 100% coverage for its 14.9 MSEK rights issue, with the subscription period opening today and running through November…
The Riksbank's 25bp rate hike to 2.0% and hawkish guidance through 2028 narrow the yield gap with the ECB, bolstering the Swedish…
Sectra expands its U.S. footprint by integrating its native reporting module into Mount Sinai Health System's enterprise imaging infrastructure to unify radiology…
BrightBid Group has commenced its rights issue period, offering existing shareholders the chance to participate through 18 November 2026, while warning of…
Boule Diagnostics proposes a massive 3-for-1 rights issue and a directed share issuance to address debt obligations and bolster liquidity, with an…
Metacon shares face pressure after Q3 2026 results revealed significant cost overruns in a flagship electrolysis project, though management maintains these expenses…
Boule Diagnostics is raising 93.2 million SEK via a rights issue to fund a business restructuring that discontinues its instrument division in…
Metacon AB faces earnings pressure in Q3 2026 due to project cost overruns, though management maintains these expenses are non-recurring and highlights…
Cheffelo achieved its first positive Q3 EBIT of MSEK 0.4 despite a 9% drop in active customers and slowing growth, as the…
Corline Biomedical projects 30 MSEK in 2027 revenue and reaffirms its long-term growth strategy, citing a fully funded business plan and significant…
NYAB AB reports robust Q3 2026 earnings and record order intake, with the Civil Engineering backlog doubling year-on-year as the firm shifts…